[#item_full_content] The Food and Drug Administration (FDA) hosted a hearing on psychedelic therapy on Monday, with the agency and other federal partners that participated taking testimony from dozens of advocates, researchers and industry participants. Eighty invited witnesses were given two minutes each to briefly summarize their stances and flag issues for federal officials. Prior to the 
Read More
FDA Psychedelics Hearing Focuses On Boosting Therapeutic Innovations While Adhering To Scientific Standards
ByPot Shop News
September 15, 2026